Efficacy News and Research

RSS
New CHAIT initiative on development of novel immunological therapeutic interventions

New CHAIT initiative on development of novel immunological therapeutic interventions

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Study explores role of L. reuteri against foodborne infection

Study explores role of L. reuteri against foodborne infection

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Silymarin does not offer significant improvements for patients with HCV

Silymarin does not offer significant improvements for patients with HCV

Studies report on therapeutic efficacy of stem cell transplantation in animal models of ALS, SCI

Studies report on therapeutic efficacy of stem cell transplantation in animal models of ALS, SCI

CPAP effectively reduces symptoms and improves QOL in sleepy patients with milder OSA

CPAP effectively reduces symptoms and improves QOL in sleepy patients with milder OSA

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Cubist second quarter total net revenues increase 30% to $230.6M

Cubist second quarter total net revenues increase 30% to $230.6M

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

Actinium completes Actimab-A Phase I/II study on Acute Myeloid Leukemia

Actinium completes Actimab-A Phase I/II study on Acute Myeloid Leukemia

Blockade Medical’s Barricade Coil System receives CE Mark

Blockade Medical’s Barricade Coil System receives CE Mark

Glanbia Nutritionals, ChromaDex to distribute pTeroPure in North America

Glanbia Nutritionals, ChromaDex to distribute pTeroPure in North America

Additional research required to assess effectiveness of herbal remedies for insomnia

Additional research required to assess effectiveness of herbal remedies for insomnia

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

Duke receives Gates Foundation grant for HIV vaccine study

Duke receives Gates Foundation grant for HIV vaccine study

Vaccination more reliable than observation for bovine herpesvirus

Vaccination more reliable than observation for bovine herpesvirus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.